Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

MARKS FIVE YEARS SINCE COVID-19 WAS FIRST DETECTED IN THE UNITED STATES, AND THE WAY WE UNDERSTAND AND RESPOND TO IT HAS EVOLVED DRAMATICALLY. WJCL 22 NEWS' LYDIA BLACKSTONE SPOKE WITH DOCTORS TODAY ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will ...

Mice were protected against lethal snake toxins for the first time, in a ‘breakthrough’ moment thanks to artificial ...

Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...